Search
for
Sort by
Research 841–870 of 1000+
- 1153 ERECTILE HEMODYNAMICS ASSESSMENT IN MEN WITH PERSISTENT ERECTILE DYSFUNCTION AFTER 5-ALPHA REDUCTASE INHIBITOR USE
- Methylated CpG dinucleotides in 5-α reductase 2 gene might explain the finasteride-resistance in BPE patients
- VIBRATIONAL SPECTROSCOPIC INVESTIGATION AND MOLECULAR STRUCTURE OF A 5α-REDUCTASE INHIBITOR: FINASTERIDE
- Combination of finasteride and tamsulosine in the treatment of male lower urinary tract symptoms: What patients are thinking about?
- Is sulfonamide group of tamsulosin main factor in the pathophysiology of floppy iris syndrome?
- Finasteride and prostate cancer
- Beeinflussen Medikamente gegen das benigne Prostatasyndrom Stimmung oder Kognition?
- Topical Application of Thermobalancing Therapy Enabled by Therapeutic Device Treats Enlarged Prostate and Improves Men's Quality of Life; New Opportunity in BPH Treatment
- Control of testosterone 5alpha-reductase activity in the human hyperplastic prostate
- 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR
- Estudio clínico-patológico sobre el cáncer de próstata incidental en pacientes intervenidos bajo el supuesto diagnóstico de HBP sintomática
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Risk factors for prostate cancer: a case‐control study in Greece
- Six weeks finasteride monotherapy before TURP: Does it improve quality of life in early post operative period?
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta.
- Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase
- 5 Alpha-reductase inhibitors: whatʼs new?
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice
- BPH: costs and treatment outcomes.
- Medikamentöse Therapie des benignen Prostatasyndroms
- 5α-Reductase: History and Clinical Importance
- Key Clinical Trials in BPH
- Editorial Comment
- Editorial Comment
- Medikamentöse Therapie des benignen Prostatasyndroms (BPS)
- Reply to finasteride and dutasteride may reduce melanoma risk
- Development of a new gas chromatography–mass spectrometry (GC–MS) methodology for the evaluation of 5α-reductase activity
- 5alpha-reductase: history and clinical importance.